unlisted recombinant protein COVID-19 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for unlisted recombinant protein COVID-19 vaccine, covering 2022-04-26 to 2022-04-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years [Phase 2]